Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion type Assertion NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_head.
- NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion description "[Knockdown of PHD2 in 786-O VHL(+) cells resulted in a more malignant phenotype in orthotopic xenografts and higher expression of specific cell cycle regulators (CDC25A, cyclin-dependent kinase 2, CCNA2) compared with VHL(-) RCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_provenance.
- NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion evidence source_evidence_literature NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_provenance.
- NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion SIO_000772 20978146 NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_provenance.
- NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion wasDerivedFrom befree-2016 NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_provenance.
- NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_assertion wasGeneratedBy ECO_0000203 NP848207.RAsEz9x5Bv30OivIO0WHzeh73YRI3O2WD8na03g5-jxlQ130_provenance.